[1]高景华,刘代远,李路广△,等.《腰椎管狭窄症中西医结合诊疗指南(2023年)》解读[J].中国中医骨伤科杂志,2025,33(01):84-87.[doi:10.20085/j.cnki.issn1005-0205.250118]
　GAO Jinghua,LIU Daiyuan,LI Luguang,et al.Interpretation of Guidelines for the Diagnosis and Treatment of Lumbar Spinal Stenosis with Integrated Traditional Chinese Medicine and Western Medicine(2023)[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2025,33(01):84-87.[doi:10.20085/j.cnki.issn1005-0205.250118]
点击复制

《腰椎管狭窄症中西医结合诊疗指南(2023年)》解读()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第33卷
期数:
2025年01期
页码:
84-87
栏目:
学者论坛
出版日期:
2025-01-15

文章信息/Info

Title:
Interpretation of Guidelines for the Diagnosis and Treatment of Lumbar Spinal Stenosis with Integrated Traditional Chinese Medicine and Western Medicine(2023)
文章编号:
1005-0205(2025)01-0084-04
作者:
高景华1; 2; 刘代远1; 李路广1△; 魏戌1; 朱立国1; 2; 高春雨1; 孙凯1; 冯敏山1; 2
1中国中医科学院望京医院(北京,100102)
2中医正骨技术北京市重点实验室
Author(s):
GAO Jinghua1; 2; LIU Daiyuan1; LI Luguang1△; WEI Xu1; ZHU Liguo1; 2; GAO Chunyu1; SUN Kai1; FENG Minshan1; 2
1Wangjing Hospital of China Academy of Chinese Medical Sciences,Beijing 100102,China; 2Beijing Key Laboratory of Chinese Medicine Zhenggu Technology,Beijing 100102,China.
关键词:
腰椎管狭窄;  诊断;  治疗;  指南解读;  中西医结合
Keywords:
lumbar spinal stenosis;  diagnosis;  treatment;  guide interpretation;  integrated traditional Chinese and Western medicine
分类号:
R681.5
DOI:
10.20085/j.cnki.issn1005-0205.250118
文献标志码:
A
摘要:
近年来,随着腰椎管狭窄症(Lumbar Spinal Stenosis,LSS)的中西医诊疗技术的发展,《腰椎管狭窄症中西医结合诊疗指南(2023年)》应时发布,该指南明确了腰椎管狭窄症的中西医结合诊断模式,规范了疾病的中医辨证和用药,并首次将中成药治疗以及中成药参与腰椎管狭窄症术后管理的内容纳入指南推荐范围内。编写过程中严格按照AGREE Ⅱ及RIGHT指南评价要求撰写,填补了国内中西医结合治疗腰椎管狭窄症领域缺少高质量指南的空白。
Abstract:
In recent years,with the development of traditional Chinese and Western medicine diagnosis and treatment technology for lumbar spinal stenosis(LSS),the Guidelines for the Diagnosis and Treatment of Lumbar Spinal Stenosis with Integrated Traditional Chinese and Western Medicine(2023)were released in due course,which clarified the diagnosis mode of LSS,standardized the syndrome differentiation and medication of traditional Chinese medicine for diseases,and included the treatment of proprietary Chinese medicine and the involvement of proprietary Chinese medicine in the postoperative management of LSS for the first time within the recommended scope of the guidelines.During the compilation process,it was written in strict accordance with the requirements of AGREE Ⅱ and RIGHT guidelines,which filled the gap of lack of high-quality guidelines in the field of integrated traditional Chinese and Western medicine in the treatment of LSS in China.

参考文献/References:

[1] KATZ J N,ZIMMERMAN Z E,MASS H,et al.Diagnosis and management of lumbar spinal stenosis:a review[J].JAMA,2022,327(17):1688-1699.
[2] JENSEN R K,HARHANGI B S,HUYGEN F,et al.Lumbar spinal stenosis[J].BMJ,2021,373:n1581.
[3] KREINER D S,SHAFFER W O,BAISDEN J L,et al.An evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spinal stenosis(update)[J].Spine J,2013,13(7):734-743.
[4] DEER T R,GRIDER J S,POPE J E,et al.The MIST guidelines:the lumbar spinal stenosis consensus group guidelines for minimally invasive spine treatment[J].Pain Pract,2019,19(3):250-274.
[5] ROUSING R,JENSEN R K,FRUENSGAARD S,et al.Danish national clinical guidelines for surgical and nonsurgical treatment of patients with lumbar spinal stenosis[J].Eur Spine J,2019,28(6):1386-1396.
[6] BUSSIÈRES A,CANCELLIERE C,AMMENDOLIA C,et al.Nonsurgical interventions for lumbar spinal stenosis leading to neurogenic claudication:a clinical practice guideline[J].J Pain,2021,22(9):1015-1039.
[7] KAWAKAMI M,TAKESHITA K,INOUE G,et al.Japanese Orthopaedic Association(JOA)clinical practice guidelines on the management of lumbar spinal stenosis,2021-Secondary publication[J].J Orthop Sci,2023,28(1):46-91.
[8] DEER T R,GRIDER J S,POPE J E,et al.Best practices for minimally invasive lumbar spinal stenosis treatment 2.0(MIST):consensus guidance from the American Society of Pain and Neuroscience(ASPN)[J].J Pain Res,2022,15:1325-1354.
[9] 腰椎管狭窄症手术治疗规范中国专家共识组.腰椎管狭窄症手术治疗规范中国专家共识(2014年)[J].中华医学杂志,2014,94(35):2724-2725.
[10] 孙树椿.中医临床诊疗指南释义:骨伤疾病分册[M].北京:中国中医药出版社,2015:143-156.
[11] 中华中医药学会.中医整脊科临床诊疗指南退变性腰椎管狭窄症:T/CACM1297-2019[S].北京:中华中医药学会,2019:43-51.
[12] 世界中医药学会联合会,中华中医药学会.国际中医临床实践指南退变性腰椎管狭窄症[J].世界中医药,2021,16(16):2371-2374.
[13] 世界中医药学会联合会骨质疏松专业委员会,上海中医药大学附属龙华医院,中日友好医院,等.腰椎管狭窄症中西医结合诊疗专家共识[J].世界中医药,2023,18(7):936-944.
[14] 中国康复医学会骨质疏松预防与康复专业委员会,中国老年保健协会骨科微创分会.退行性腰椎管狭窄症诊疗专家共识[J].中华骨与关节外科杂志,2023,16(2):97-103.
[15] 左世国,庹绍彬,侯智颖,等.中药治疗腰椎管狭窄症的临床研究进展[J].中国中医急症,2021,30(8):1497-1500.
[16] 姚德威,成西侠,邹继伟,等.腰椎管狭窄平衡功能的足底压力分析[J].中国矫形外科杂志,2022,30(10):947-950.
[17] 熊毛武.补阳还五汤治疗退变性腰椎管狭窄所致腰腿痛30例[J].湖南中医杂志,2005,21(3):51.
[18] 康世林.补阳还五汤治疗退变性腰椎管狭窄73例[J].中医杂志,2010,51(S2):195-196.
[19] 王吉庆,顾敬东,金浪,等.补阳还五汤治疗退变性腰椎管狭窄症作用机制研究[J].辽宁中医杂志,2023,50(10):132-135.
[20] 张劲新,刘万鹏,陈茂水,等.独活寄生汤加减治疗退变性腰椎管狭窄症的疗效及对血流变学指标的影响[J].陕西中医,2017,38(5):596-598.
[21] 崔立军.独活寄生汤加减治疗退变性腰椎管狭窄症的疗效及对血流变学指标的影响[J].当代医学,2020,26(32):182-183.
[22] 张成光,张锟,王特哈斯,等.独活寄生汤治疗腰椎管狭窄症临床有效性研究[J].湖北中医药大学学报,2021,23(4):91-93.
[23] 李颖,谢兆林,甘锋平.独活寄生汤加减联合地奥司明治疗腰椎管狭窄症的临床研究[J].现代中西医结合杂志,2022,31(4):525-527.
[24] 高仲谋.丹鹿通督片治疗腰椎管狭窄症的临床观察[J].中国伤残医学,2015,23(19):92-94.
[25] 吴秀蓉,张婷婷.康复理疗联合丹鹿通督片治疗腰椎管狭窄症的疗效观察[J].北方药学,2018,15(9):192-193.
[26] 周荣富.探讨康复理疗联合丹鹿通督片治疗腰椎管狭窄症的疗效[J].养生保健指南,2020(1):261.
[27] 潘小燕,张燕娟,郎贤伟,等.退行性腰椎管狭窄症中医药治疗进展[J].中国乡村医药,2024,31(12):64-66.
[28] 潘珺俊,冯敏山,徐惠青,等.基于文献研究的针刀治疗不良事件现状统计及对策分析[J].北京中医药,2021,40(12):1310-1320.
[29] PRYZBYLKOWSKI P,BUX A,CHANDWANI K,et al.Minimally invasive direct decompression for lumbar spinal stenosis:impact of multiple prior epidural steroid injections[J].Pain Manag,2022,12(2):149-158.
[30] STAATS P S,HAGEDORN J M,REECE D E,et al.Percutaneous image-guided lumbar decompression and interspinous spacers for the treatment of lumbar spinal stenosis:a 2-year medicare claims benchmark study[J].Pain Pract,2023,23(7):776-784.
[31] 黄文茁,黎登宸,谢添.基于网络药理学探讨补阳还五汤治疗腰椎术后疼痛综合征的作用机制[J].中医临床研究,2023,15(35):1-9.

备注/Memo

备注/Memo:
基金项目:北京市中医药科技发展资金项目(BJZYQN-2023-28)
国家中医药管理局项目(ZYZB-2022-798)
△通信作者 E-mail:2272989418@qq.com
更新日期/Last Update: 2025-01-15